Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for ...

More than six million Americans are living with heart failure and over 900,000 new cases are being diagnosed each year. By the year 2030, the American Heart Association predicts nearly ...

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

A heart can never rest. That creates a problem for a heart that has lost muscle tissue. “Skeletal muscle has a significant ...

The actress has been supporting calls for greater awareness of heart failure, which, according to the PHA, is a complex ...

Infection-related hospitalization (IRH) is associated with incident heart failure, heart failure with preserved ejection ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Heart transplants are complex, costly, and risky—but for patients with heart failure, they are often the only option for ...

Research Triangle Park, North Carolina Saturday, February 15, 2025, 17:00 Hrs [IST] ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...